AC
Avestar Capital Portfolio holdings
AUM
$1.37B
1-Year Return
19.87%
This Quarter Return
+7.21%
1 Year Return
+19.87%
3 Year Return
+72.2%
5 Year Return
+112.69%
10 Year Return
–
AUM
$809M
AUM Growth
+$153M
(+23%)
Cap. Flow
+$105M
Cap. Flow
% of AUM
12.96%
Top 10 Holdings %
Top 10 Hldgs %
41.07%
Holding
390
New
65
Increased
197
Reduced
82
Closed
35
Top Buys
Top Sells
Sector Composition
| 1 | Technology | 14.85% |
| 2 | Communication Services | 10.16% |
| 3 | Consumer Discretionary | 4.61% |
| 4 | Financials | 3.21% |
| 5 | Healthcare | 3.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Xcel Energy
XEL
$43B
| $339K | 0.04% |
5,428
+729
| +16% | +$45.5K |
|
252
Blackrock
BLK
$170B
| $339K | 0.04% |
417
-41
| -9% | -$33.3K |
|
253
W.W. Grainger
GWW
$47.5B
| $336K | 0.04% |
405
+21
| +5% | +$17.4K |
|
254
Automatic Data Processing
ADP
$120B
| $335K | 0.04% |
1,430
+430
| +43% | +$101K |
|
255
Progressive
PGR
$143B
| $334K | 0.04% |
2,099
+421
| +25% | +$67.1K |
|
256
KLA
KLAC
$119B
| $330K | 0.04% |
+567
| New | +$330K |
|
257
Prologis
PLD
$105B
| $328K | 0.04% |
2,463
+606
| +33% | +$80.8K |
|
258
AstraZeneca
AZN
$253B
| $327K | 0.04% |
4,862
+37
| +0.8% | +$2.49K |
|
259
Vontier
VNT
$6.37B
| $325K | 0.04% |
9,414
-111
| -1% | -$3.84K |
|
260
Fluor
FLR
$6.72B
| $324K | 0.04% |
8,261
-694
| -8% | -$27.2K |
|
261
Regeneron Pharmaceuticals
REGN
$60.8B
| $321K | 0.04% |
+365
| New | +$321K |
|
262
Hubbell
HUBB
$23.2B
| $319K | 0.04% |
971
+45
| +5% | +$14.8K |
|
263
Ford
F
$46.7B
| $319K | 0.04% |
26,174
-11,151
| -30% | -$136K |
|
264
Invesco S&P MidCap 400 Revenue ETF
RWK
$999M
| $318K | 0.04% |
+3,023
| New | +$318K |
|
265
Charles River Laboratories
CRL
$8.07B
| $315K | 0.04% |
1,331
-119
| -8% | -$28.1K |
|
266
Vanguard Russell 2000 ETF
VTWO
$12.8B
| $306K | 0.03% |
3,773
| – | – |
|
267
Chubb
CB
$111B
| $306K | 0.03% |
1,349
+259
| +24% | +$58.7K |
|
268
Southern Company
SO
$101B
| $306K | 0.03% |
4,361
+900
| +26% | +$63.1K |
|
269
Bristol-Myers Squibb
BMY
$96B
| $303K | 0.03% |
5,903
+197
| +3% | +$10.1K |
|
270
DexCom
DXCM
$31.6B
| $303K | 0.03% |
+2,440
| New | +$303K |
|
271
Zscaler
ZS
$42.7B
| $302K | 0.03% |
1,361
+584
| +75% | +$129K |
|
272
PACCAR
PCAR
$52B
| $302K | 0.03% |
+3,009
| New | +$302K |
|
273
BWX Technologies
BWXT
$15B
| $297K | 0.03% |
3,877
-175
| -4% | -$13.4K |
|
274
Hershey
HSY
$37.6B
| $297K | 0.03% |
1,592
+19
| +1% | +$3.54K |
|
275
First American
FAF
$6.83B
| $297K | 0.03% |
4,603
-287
| -6% | -$18.5K |
|